BiotechTubeBiotechTube
Home/Mineralys Therapeutics/Jon Congleton
JC

Jon Congleton

Chief Executive Officer

Mineralys Therapeutics

Therapeutic Areas

CardiovascularHypertensionNephrology

Mineralys Therapeutics Pipeline

DrugIndicationPhase
Lorundrostat (MLS-101)Uncontrolled HypertensionPhase 2
Next-generation aldosterone synthase inhibitorsHypertensionPreclinical

Leadership Team at Mineralys Therapeutics

AL
Adam Levy
Chief Medical Officer
BJ
Brian J. Dziewior
Chief Financial Officer
DR
David Rodman
Chief Development Officer
MK
Minji Kim
Chief Scientific Officer
BJ
Brian J. Dziewior
Director
DR
David Rodman
Director
MK
Minji Kim
Director
BJ
Brian J.G. Pereira
Chairman of the Board
EW
Elise Wang
Director
CY
Christopher Y. Chai
Director
View full Mineralys Therapeutics profile